|
US6184344B1
(en)
*
|
1995-05-04 |
2001-02-06 |
The Scripps Research Institute |
Synthesis of proteins by native chemical ligation
|
|
US6849428B1
(en)
*
|
1997-03-05 |
2005-02-01 |
New England Biolabs, Inc. |
Intein-mediated protein ligation of expressed proteins
|
|
DE69837170T2
(de)
*
|
1997-06-13 |
2007-11-22 |
Amylin Pharmaceuticals, Inc., San Diego |
Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen
|
|
US6844161B2
(en)
|
1997-09-04 |
2005-01-18 |
Gryphon Therapeutics, Inc. |
Modular protein libraries and methods of preparation
|
|
AUPP589598A0
(en)
|
1998-09-14 |
1998-10-08 |
University Of Queensland, The |
Novel peptides
|
|
US7001745B1
(en)
*
|
1998-09-30 |
2006-02-21 |
New England Biolabs, Inc. |
Intein mediated peptide ligation
|
|
EP1159289A1
(en)
*
|
1999-03-11 |
2001-12-05 |
Gryphon Sciences |
Chemical synthesis and use of soluble membrane protein receptor domains
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
EP1307214A4
(en)
*
|
2000-08-11 |
2006-01-18 |
Invitrogen Corp |
HIGHLY HOMOGENEOUS MOLECULAR MARKERS FOR ECTROPHORESIS
|
|
US20040014082A1
(en)
*
|
2000-08-11 |
2004-01-22 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
|
US6977292B2
(en)
*
|
2000-09-01 |
2005-12-20 |
Gryphon Therapeutics |
Nucleophile-stable thioester generating compounds, methods of production and use
|
|
US7273923B2
(en)
*
|
2001-01-22 |
2007-09-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
ATE346950T1
(de)
*
|
2001-03-09 |
2006-12-15 |
Boston Probes Inc |
Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen
|
|
GB0113657D0
(en)
*
|
2001-06-05 |
2001-07-25 |
Geneprot Inc |
Improved native chemical ligation with three or more components
|
|
EP2292273A3
(en)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
|
WO2003106615A2
(en)
*
|
2002-06-10 |
2003-12-24 |
Geneprot, Inc. |
Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
|
|
ATE312605T1
(de)
*
|
2002-06-29 |
2005-12-15 |
Aquanova Ger Solubilisate Tech |
Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
|
|
US7166574B2
(en)
*
|
2002-08-20 |
2007-01-23 |
Biosurface Engineering Technologies, Inc. |
Synthetic heparin-binding growth factor analogs
|
|
US7598224B2
(en)
|
2002-08-20 |
2009-10-06 |
Biosurface Engineering Technologies, Inc. |
Dual chain synthetic heparin-binding growth factor analogs
|
|
US8227411B2
(en)
|
2002-08-20 |
2012-07-24 |
BioSurface Engineering Technologies, Incle |
FGF growth factor analogs
|
|
WO2004053460A2
(en)
*
|
2002-12-11 |
2004-06-24 |
New England Biolabs, Inc. |
Carrier-ligand fusions and uses thereof
|
|
US8034900B2
(en)
*
|
2002-12-30 |
2011-10-11 |
Amylin Pharmaceuticals, Inc. |
Water-soluble thioester and selenoester compounds and methods for making and using the same
|
|
CA2522345A1
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
SI1624891T2
(sl)
*
|
2003-05-06 |
2013-09-30 |
Biogen Idec Hemophilia Inc. |
Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije
|
|
WO2004105685A2
(en)
*
|
2003-05-22 |
2004-12-09 |
Gryphon Therapeutics, Inc. |
Displaceable linker solid phase chemical ligation
|
|
US7414028B1
(en)
|
2004-02-04 |
2008-08-19 |
Biosurface Engineering Technologies, Inc. |
Growth factor analogs
|
|
US20080227696A1
(en)
|
2005-02-22 |
2008-09-18 |
Biosurface Engineering Technologies, Inc. |
Single branch heparin-binding growth factor analogs
|
|
US20060024347A1
(en)
*
|
2004-02-10 |
2006-02-02 |
Biosurface Engineering Technologies, Inc. |
Bioactive peptide coatings
|
|
US7671012B2
(en)
|
2004-02-10 |
2010-03-02 |
Biosurface Engineering Technologies, Inc. |
Formulations and methods for delivery of growth factor analogs
|
|
US7528105B1
(en)
|
2004-02-10 |
2009-05-05 |
Biosurface Engineering Technologies |
Heterodimeric chain synthetic heparin-binding growth factor analogs
|
|
JP4895826B2
(ja)
|
2004-02-20 |
2012-03-14 |
バイオサーフェス エンジニアリング テクノロジーズ,インク. |
骨形成蛋白−2の正のモジュレーター
|
|
US7910593B2
(en)
|
2004-04-09 |
2011-03-22 |
Chugai Seiyaku Kabushiki Kaisha |
Water-soluble prodrugs
|
|
EP1749022A2
(en)
*
|
2004-05-24 |
2007-02-07 |
Rigel Pharmaceuticals, Inc. |
Methods for cyclizing synthetic polymers
|
|
KR20080003849A
(ko)
|
2005-03-31 |
2008-01-08 |
아밀린 파마슈티칼스, 인크. |
비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법
|
|
TW200744603A
(en)
|
2005-08-22 |
2007-12-16 |
Chugai Pharmaceutical Co Ltd |
Novel anticancer concomitant drug
|
|
US7674881B2
(en)
*
|
2005-10-07 |
2010-03-09 |
The University Of Chicago |
Convergent synthesis of proteins by kinetically controlled ligation
|
|
US20090118271A1
(en)
*
|
2005-10-19 |
2009-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
|
|
US7820172B1
(en)
|
2006-06-01 |
2010-10-26 |
Biosurface Engineering Technologies, Inc. |
Laminin-derived multi-domain peptides
|
|
CA2692240C
(en)
|
2006-06-22 |
2018-03-13 |
Biosurface Engineering Technologies, Inc. |
Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
|
|
EP2120985B1
(en)
|
2007-02-05 |
2012-06-27 |
Amylin Pharmaceuticals, Inc. |
FN-38 peptides for use in the treatment of psychotic and anxiety disorders
|
|
WO2009032133A2
(en)
*
|
2007-08-28 |
2009-03-12 |
Ipsen Pharma S.A.S. |
Methods and intermediates for chemical synthesis of polypeptides and proteins
|
|
EP2536287A4
(en)
*
|
2010-02-18 |
2015-10-07 |
Advanced Proteome Therapeutics Inc |
SPECIFIC SITE SIZE OF PROTEINS USING CHEMICAL MODIFICATION TO PROMOTE PROTEIN CONJUGATE FORMATION, PROTEIN DIMER FORMATION, AND AGRAFTED PEPTIDES
|
|
MX349054B
(es)
|
2010-09-28 |
2017-07-07 |
Aegerion Pharmaceuticals Inc |
Leptinas altamente solubles.
|
|
BR112013007442A2
(pt)
|
2010-09-28 |
2019-09-24 |
Amylin Pharmaceuticals Llc |
polipeptídeos construídos tendo duração de ação realçada
|
|
DK2729160T3
(da)
|
2011-07-08 |
2019-07-01 |
Aegerion Pharmaceuticals Inc |
Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet
|
|
JP6006309B2
(ja)
|
2011-07-08 |
2016-10-12 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド
|
|
FR2981352B1
(fr)
*
|
2011-10-17 |
2015-07-03 |
Centre Nat Rech Scient |
Procede de synthese de proteines
|
|
US9545449B2
(en)
|
2012-05-11 |
2017-01-17 |
Advanced Proteone Therapeutics Inc. |
Site-specific labeling and targeted delivery of proteins for the treatment of cancer
|
|
WO2013177231A1
(en)
|
2012-05-21 |
2013-11-28 |
Massachusetts Institute Of Technology |
Translocation of non-natural chemical entities through anthrax protective antigen pore
|
|
SG11201505926VA
(en)
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
|
US11273176B2
(en)
|
2016-03-02 |
2022-03-15 |
The Brigham And Women's Hospital, Inc. |
Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
|
|
EP3590951A4
(en)
*
|
2017-03-02 |
2021-01-06 |
Glytech, Inc. |
PROCESS FOR PRODUCING AN AMINO ACID POLYMER
|
|
KR20210072021A
(ko)
|
2018-10-01 |
2021-06-16 |
유니베르시떼 드 제네브 |
생물학 분석에 적합한 복수의 폴리펩티드 변이체의 생산 방법
|
|
KR102769851B1
(ko)
*
|
2018-11-30 |
2025-02-20 |
가부시키가이샤 도우사 고가쿠 겐큐쇼 |
펩티드 티오에스테르 및 펩티드의 신규 제조 방법
|
|
AU2020361681A1
(en)
|
2019-10-10 |
2022-05-05 |
1859, Inc. |
Methods and systems for microfluidic screening
|
|
US20210230218A1
(en)
*
|
2019-10-23 |
2021-07-29 |
Mabplex International, Ltd. |
Oligopeptide linker intermediate and preparation method thereof
|
|
WO2022266467A2
(en)
|
2021-06-17 |
2022-12-22 |
Dana-Farber Cancer Institute, Inc. |
Recombinant histone polypeptide and uses thereof
|
|
WO2024146707A1
(en)
|
2023-01-06 |
2024-07-11 |
Université De Genève |
Variant ligand conjugates for payload delivery
|